These results suggest that the inhibition of mTOR kinase does not play a significant role in the observed synergy and the inhibition of both DNA-PK and ATM may be essential for blocking cancer cell survival after DNA damage in ATM-proficient cells. Here, PRKDC is linked to cancer.